|
[1]
|
Shiha, G., et al. (2017) Asian-Pacific Association for the Study of the Liver (APASL) Consensus Guidelines on Invasive and Non-Invasive Assessment of Hepatic Fibrosis: A 2016 Update. Hepatology International, 11, 1-30.
|
|
[2]
|
王麟, 等. 2015年欧洲肝病学会与拉丁美洲肝病学会无创检查评估肝脏疾病严重程度及预后临床指南要点[J]. 中华肝脏病杂志, 2015, 23(7): 488-492.
|
|
[3]
|
王贵强, 等. 慢性乙型肝炎防治指南(2019年版) [J]. 肝脏, 2019, 24(12): 6-27.
|
|
[4]
|
Razavi-Shearer, D., et al. (2018) Global Prevalence, Treatment, and Prevention of Hepatitis B Virus Infection in 2016: A Modelling Study. The Lancet Gastroenterology and Hepatology, 3, 383-403. [Google Scholar] [CrossRef]
|
|
[5]
|
Lee, H.M. and Banini, B.A. (2019) Updates on Chronic HBV: Current Challenges and Future Goals. Current Treatment Options in Gastroenterology, 17, 271-291. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Chang, T.-T., et al. (2010) Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B. Hepatology, 52, 886-893.
|
|
[7]
|
Schiff, E.R., et al. (2011) Long-Term Treatment with Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients with Chronic Hepatitis B. Clinical Gastroenterology and Hepatology, 9, 274-276.e1. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
孔媛媛, 等. 慢性乙型肝炎患者肝脏硬度值下降趋势与肝纤维化逆转结局的关系[J]. 临床肝胆病杂志, 2020, 36(2): 76-80.
|
|
[9]
|
Shihua, G., Ibrahim, A., Helmy, A., et al. (2016) An Excerpt of Asian-Pacific Association for the Study of the Liver (APASL) Consensus Guidelines on Invasive and Non-Invasive Assessment of Hepatic Fibrosis. Journal of Clinical Hepatology, 11, 1-30.
|
|
[10]
|
Singh, S., et al. (2017) American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. Gastroenterology, 152, 1544-1577. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Teshale, E., et al. (2015) APRI and FIB-4 Are Good Predictors of the Stage of Liver Fibrosis in Chronic Hepatitis B: The Chronic Hepatitis Cohort Study (CHeCS). Journal of Viral Hepatitis, 21, 917-920. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Lee, H.W., et al. (2016) Red Cell Volume Distribution Width-to-Platelet Ratio in Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B. Liver International, 36, 24-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Hu, Y.-C., et al. (2017) Value of Gamma-Glutamyltranspeptidase-to-Platelet Ratio in Diagnosis of Hepatic Fibrosis in Patients with Chronic Hepatitis B. World Journal of Gastroenterology, 23, 7425-7432. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Lemoine, M., et al. (2016) The Gamma-Glutamyl Transpeptidase to Platelet Ratio (GPR) Predicts Significant Liver Fibrosis and Cirrhosis in Patients with Chronic HBV Infection in West Africa. Gut, 65, 1369-1376. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
张晶巧, 等. 《2018年美国肝病学会乙型肝炎指引声明意见: 慢性乙型肝炎的预防, 诊断和治疗》摘译[J]. 临床肝胆病杂志, 2018, 34(4): 64-69.
|
|
[16]
|
廖雪姣, 等. 637例慢性HBV感染者自然史各期肝组织纤维化演变规律研究[J]. 中国肝脏病杂志: 电子版, 2014(2): 1-5.
|
|
[17]
|
徐洪海, 郜玉峰. King指数无创诊断慢性HBV感染患者肝纤维化程度的预测价值[J]. 安徽医学, 2020, 41(5): 505-509.
|